Over 4,000 people enroll in Phase II trial of local COVID-19 vaccine
03/30/2021 08:30 PM
Over 4,000 people in Taiwan have enrolled in the second-stage clinical trial of a domestic COVID-19 vaccine, of whom around 3,700 have already received an injection, the vaccine's developer, Medigen Vaccine Biologics Corp. (MVC), announced Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
U.S. introduces bill to combat China's sabotage of Taiwan's underseas cables
07/10/2025 11:13 AM - Society
Taiwan headline news
07/10/2025 10:38 AM - Business
U.S. dollar up in Taipei trading
07/10/2025 10:29 AM - Society
Rain likely to continue across Taiwan on Thursday
07/10/2025 10:06 AM - Business
Taiwan shares open higher
07/10/2025 09:09 AM